Edition:
United States

Protalix Biotherapeutics Inc (PLX)

PLX on American Stock Exchange

0.59USD
21 Sep 2017
Change (% chg)

$-0.02 (-3.75%)
Prev Close
$0.61
Open
$0.60
Day's High
$0.61
Day's Low
$0.58
Volume
218,036
Avg. Vol
698,820
52-wk High
$1.51
52-wk Low
$0.26

Chart for

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.21
Market Cap(Mil.): ₪287.39
Shares Outstanding(Mil.): 133.35
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 78.94 16.33
EPS (TTM): -- -- --
ROI: -- 2.84 14.66
ROE: -- 4.61 13.99

Earnings vs. Estimates